Big Pharma Is Pouring Billions Into a New Class of βProtein Degraderβ Drugs
New medications are showing promise in going after a certain kind of hard-to-target protein in diseased cells.
Β© Getty Images/Science Photo Library
Β© Getty Images/Science Photo Library